Related references
Note: Only part of the references are listed.Therapeutic Immune Modulation against Solid Cancers with Intratumoral Poly-ICLC: A Pilot Trial
Chrisann Kyi et al.
CLINICAL CANCER RESEARCH (2018)
TLR8 combined withTLR3 or TLR4 agonists enhances DC-NK driven effector Tc1 cells
Mahyar Nouri-Shirazi et al.
IMMUNOLOGY LETTERS (2018)
TLR7 agonists induce transient viremia and reduce the viral reservoir in SIV-infected rhesus macaques on antiretroviral therapy
So-Yon Lim et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Towards superior dendritic-cell vaccines for cancer therapy
Mansi Saxena et al.
NATURE BIOMEDICAL ENGINEERING (2018)
Barriers for HIV Cure: The Latent Reservoir
Sergio Castro-Gonzalez et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2018)
Large-Scale Human Dendritic Cell Differentiation Revealing Notch-Dependent Lineage Bifurcation and Heterogeneity
Sreekumar Balan et al.
CELL REPORTS (2018)
NY-ESO-1 Vaccination in Combination with Decitabine Induces Antigen-Specific T-lymphocyte Responses in Patients with Myelodysplastic Syndrome
Elizabeth A. Griffiths et al.
CLINICAL CANCER RESEARCH (2018)
WT1 peptide vaccine in Montanide in contrast to poly ICLC, is able to induce WT1-specific immune response with TCR clonal enrichment in myeloid leukemia
Hongtao Liu et al.
EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2018)
Re-Emergence of Dendritic Cell Vaccines for Cancer Treatment
Mansi Saxena et al.
TRENDS IN CANCER (2018)
Toll-Like Receptor 7 Agonist GS-9620 Induces HIV Expression and HIV-Specific Immunity in Cells from HIV-Infected Individuals on Suppressive Antiretroviral Therapy
Angela Tsai et al.
JOURNAL OF VIROLOGY (2017)
Toll-like receptor 3 activation selectively reverses HIV latency in microglial cells
David Alvarez-Carbonell et al.
RETROVIROLOGY (2017)
Human innate responses and adjuvant activity of TLR ligands in vivo in mice reconstituted with a human immune system
Liang Cheng et al.
VACCINE (2017)
The Toll for Trafficking: Toll-Like Receptor 7 Delivery to the endosome
Carlene Petes et al.
FRONTIERS IN IMMUNOLOGY (2017)
Turbocharging vaccines: emerging adjuvants for dendritic cell based therapeutic cancer vaccines
Mansi Saxena et al.
CURRENT OPINION IN IMMUNOLOGY (2017)
Short-Course Toll-Like Receptor 9 Agonist Treatment Impacts Innate Immunity and Plasma Viremia in Individuals With Human Immunodeficiency Virus Infection
Line Vibholm et al.
CLINICAL INFECTIOUS DISEASES (2017)
IL-15 signaling in NK cell cancer immunotherapy
Jai Rautela et al.
CURRENT OPINION IN IMMUNOLOGY (2017)
Modulation of innate immunity in the tumor microenvironment
Elena Gonzalez-Gugel et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2016)
HIV infection: focus on the innate immune cells
Milena S. Espindola et al.
IMMUNOLOGIC RESEARCH (2016)
A Novel Toll-Like Receptor 9 Agonist, MGN1703, Enhances HIV-1 Transcription and NK Cell-Mediated Inhibition of HIV-1-Infected Autologous CD4+ T Cells
Rasmus Offersen et al.
JOURNAL OF VIROLOGY (2016)
Type 1 interferon licenses naive CD8 T cells to mediate anti-viral cytotoxicity
Stina L. Urban et al.
VIROLOGY (2016)
A Subset of Latency-Reversing Agents Expose HIV-Infected Resting CD4+ T-Cells to Recognition by Cytotoxic T-Lymphocytes
R. Brad Jones et al.
PLOS PATHOGENS (2016)
Targeting HIV-1 Env gp140 to LOX-1 Elicits Immune Responses in Rhesus Macaques
Gerard Zurawski et al.
PLOS ONE (2016)
PolyICLC Exerts Pro- and Anti-HIV Effects on the DC-T Cell Milieu In Vitro and In Vivo
Meropi Aravantinou et al.
PLOS ONE (2016)
Toll-Like Receptor Signaling and Its Inducible Proteins
Takashi Satoh et al.
MICROBIOLOGY SPECTRUM (2016)
Soluble CD40 ligand contributes to dendritic cell-mediated T-cell dysfunction in HIV-1 infection
Elizabeth A. Miller et al.
AIDS (2015)
Attenuated Listeria monocytogenes Vectors Overcome Suppressive Plasma Factors During HIV Infection to Stimulate Myeloid Dendritic Cells to Promote Adaptive Immunity and Reactivation of Latent Virus
Elizabeth A. Miller et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2015)
Autologous aldrithiol-2-inactivated HIV-1 combined with polyinosinic-polycytidylic acid poly-L-lysine carboxymethylcellulose as a vaccine platform for therapeutic dendritic cell immunotherapy
Elizabeth Miller et al.
VACCINE (2015)
Induction of Robust Type-I CD8+ T-cell Responses in WHO Grade 2 Low-Grade Glioma Patients Receiving Peptide-Based Vaccines in Combination with Poly-ICLC
Hideho Okada et al.
CLINICAL CANCER RESEARCH (2015)
Vaccine adjuvant uses of poly-IC and derivatives
Karen Ao Martins et al.
EXPERT REVIEW OF VACCINES (2015)
A Randomized Open-Label Study of 3-Versus 5-Drug Combination Antiretroviral Therapy in Newly HIV-1-Infected Individuals
Martin Markowitz et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2014)
Induction of Antigen-Specific Immunity with a Vaccine Targeting NY-ESO-1 to the Dendritic Cell Receptor DEC-205
Madhav V. Dhodapkar et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
HIV-1 Latency: An Update of Molecular Mechanisms and Therapeutic Strategies
Angela Battistini et al.
VIRUSES-BASEL (2014)
Therapeutic In Situ Autovaccination against Solid Cancers with Intratumoral Poly-ICLC: Case Report, Hypothesis, and Clinical Trial
Andres M. Salazar et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Reversal of NK-Cell Exhaustion in Advanced Melanoma by Tim-3 Blockade
Ines Pires da Silva et al.
CANCER IMMUNOLOGY RESEARCH (2014)
NOD-like receptors: master regulators of inflammation and cancer
Mansi Saxena et al.
FRONTIERS IN IMMUNOLOGY (2014)
TLR/NCR/KIR: which one to use and when?
Simona Sivori et al.
FRONTIERS IN IMMUNOLOGY (2014)
CD38 and CD157: A long journey from activation markers to multifunctional molecules
Valeria Quarona et al.
CYTOMETRY PART B-CLINICAL CYTOMETRY (2013)
Polyinosinic-Polycytidylic Acid Is the Most Effective TLR Adjuvant for SIV Gag Protein-Induced T Cell Responses In Nonhuman Primates
Haesun Park et al.
JOURNAL OF IMMUNOLOGY (2013)
Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs
Christine Katlama et al.
LANCET (2013)
The search for an HIV cure: tackling latent infection
Stephen J. Kent et al.
LANCET INFECTIOUS DISEASES (2013)
Healthy Neonates Possess a CD56-Negative NK Cell Population with Reduced Anti-Viral Activity
Amanda Jacobson et al.
PLOS ONE (2013)
Reactivation of latent HIV-1 in central memory CD4+ T cells through TLR-1/2 stimulation
Camille L. Novis et al.
RETROVIROLOGY (2013)
CD56negCD16+ NK cells are activated mature NK cells with impaired effector function during HIV-1 infection
Jeffrey M. Milush et al.
RETROVIROLOGY (2013)
Effect of Montanide and Poly-ICLC Adjuvant on Human Self/Tumor Antigen-Specific CD4+ T Cells in Phase I Overlapping Long Peptide Vaccine Trial
Takemasa Tsuji et al.
CANCER IMMUNOLOGY RESEARCH (2013)
Differential regulation of toll-like receptor pathways in acute and chronic HIV-1 infection
J. Judy Chang et al.
AIDS (2012)
Plasma Factors During Chronic HIV-1 Infection Impair IL-12 Secretion by Myeloid Dendritic Cells via a Virus-Independent Pathway
Elizabeth A. Miller et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2012)
HIV-1 infection-induced apoptotic microparticles inhibit human DCs via CD44
Davor Frleta et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy
N. M. Archin et al.
NATURE (2012)
DDX1, DDX21, and DHX36 Helicases Form a Complex with the Adaptor Molecule TRIF to Sense dsRNA in Dendritic Cells
Zhiqiang Zhang et al.
IMMUNITY (2011)
Tenofovir Selectively Regulates Production of Inflammatory CytokinesandShifts the IL-12/IL-10 Balance in Human Primary Cells
Jesper Melchjorsen et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2011)
Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humans
Marina Caskey et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Immunization with HIV Gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primates
Barbara J. Flynn et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Phosphorylation at serine 318 is not required for inhibition of T cell activation by ALX
Michael J. Shapiro et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
A Tonsillar PolyICLC/AT-2 SIV Therapeutic Vaccine Maintains Low Viremia Following Antiretroviral Therapy Cessation
Panagiotis Vagenas et al.
PLOS ONE (2010)
Distinct and complementary functions of MDA5 and TLR3 in poly(I:C)-mediated activation of mouse NK cells
Stephen McCartney et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant
M. Paula Longhi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Monocyte-Derived Dendritic Cells from HIV Type 1-Infected Individuals Show Reduced Ability to Stimulate T Cells and Have Altered Production of Interleukin (IL)-12 and IL-10
Sandrine Buisson et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
TLR3:: Interferon induction by double-stranded RNA including poly(I:C)
Misako Matsumoto et al.
ADVANCED DRUG DELIVERY REVIEWS (2008)
Antitumor NK activation induced by the Toll-like receptor 3-TICAM-1 (TRIF) pathway in myeloid dendritic cells
Takashi Akazawa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Differential regulation of T-cell growth by IL-2 and IL-15
Georgina H. Cornish et al.
BLOOD (2006)
HIV-1-infected dendritic cells up-regulate cell surface markers but fail to produce IL-12 p70 in response to CD40 ligand stimulation
A Smed-Sörensen et al.
BLOOD (2004)
New real-time reverse transcriptase-initiated PCR assay with single-copy sensitivity for human immunodeficiency virus type 1 RNA in plasma
S Palmer et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2003)
Share Paper
